Skip to main navigation

Top Bar

  • info@eledon.com
  • +1 949.238.8090
Eledon Pharmaceuticals - logo

Main navigation

  • Home
  • About Us
    • Company Overview
    • Leadership Team
    • Board of Directors
    • Governance
  • R&D
    • R&D Overview
    • CD40L Pathway
    • Pipeline
    • AT-1501
    • Phase 1 KLH Challenge
  • Investors
    • News
    • Events
    • Presentations
    • Stock Information
    • SEC Filings
    • Governance
    • Investor FAQs
    • Contact
  • Join the team
  • Contact Us

Investors

Investor Relations

  • Investors
  • News
  • Events
  • Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Investor FAQs
  • Contact Investor Relations
  • Ethics Hotline

News


Date Title
05/05/2016 Summary ToggleTokai Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
04/26/2016 Summary ToggleTokai Announces Oral Presentation on Galeterone at the 2016 AUA Annual Meeting
04/13/2016 Summary ToggleTokai Announces Presentations on Galeterone at the AACR Annual Meeting 2016
04/06/2016 Summary ToggleTokai Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference
03/30/2016 Summary ToggleTokai Announces Dosing of First Patient in Phase 2 Expansion Study of Galeterone in Enzalutamide-Refractory mCRPC Patients
03/21/2016 Summary ToggleTokai Strengthens Development Team Through the Addition of Kelly Lindert, M.D., as Executive Vice President and Head of Development
03/10/2016 Summary ToggleOticPharma to Present at the 28th Annual ROTH Conference
03/10/2016 Summary ToggleTokai Pharmaceuticals Reports Full Year 2015 Financial Results
02/22/2016 Summary ToggleOticPharma to Present at the 2016 BIO CEO & Investor Conference
01/08/2016 Summary ToggleTokai Announces Presentation of New Data Highlighting Unique Galeterone Mechanism at ASCO Genitourinary Cancers Symposium

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Next page Next
  • Last page Last
Displaying 121 - 130 of 131 results

Toolkit

Print Page Email Alerts RSS Feeds Contact

Footer

Quick links

  • Home
  • About Us
  • CD40L Pathway
  • Pipeline
  • AT-1501
  • KLH Challenge
  • Contact Us

Footer Investor Links

  • Investors
  • Press Releases
  • Governance
  • Stock Information
  • SEC Filings
  • Investor Email List
© 2023 Eledon Pharmaceuticals, Inc. - All Rights Reserved.